Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tradipitant by Vanda Pharmaceuticals for Functional (Non Ulcer) Dyspepsia: Likelihood of Approval
Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Functional (Non Ulcer) Dyspepsia. According to...
Data Insights
Tradipitant by Vanda Pharmaceuticals for Motion Sickness: Likelihood of Approval
Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Motion Sickness. According to GlobalData, Phase...